Evidence map›Paper›PMID 34094079›Full record

ArticleChemical science2020

Enantio- and diastereoselective conjugate borylation/Mannich cyclization.

Egor M Larin, Joachim Loup, Iuliia Polishchuk, Rachel J Ross, Andrew Whyte, Mark Lautens

Abstract read
In one paragraph

Article in Chemical science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Chemical science · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Egor M LarinDavenport Laboratories, Department of Chemistry, University of Toronto 80 St. George St. Toronto Ontario M5S 3H6 Canada mark.lautens@utoronto.ca.ORCID https://orcid.org/0000-0003-4986-1373
Joachim LoupDavenport Laboratories, Department of Chemistry, University of Toronto 80 St. George St. Toronto Ontario M5S 3H6 Canada mark.lautens@utoronto.ca.ORCID https://orcid.org/0000-0002-0033-5033
Iuliia PolishchukDavenport Laboratories, Department of Chemistry, University of Toronto 80 St. George St. Toronto Ontario M5S 3H6 Canada mark.lautens@utoronto.ca.ORCID https://orcid.org/0000-0002-8622-0455
Rachel J RossDavenport Laboratories, Department of Chemistry, University of Toronto 80 St. George St. Toronto Ontario M5S 3H6 Canada mark.lautens@utoronto.ca.ORCID https://orcid.org/0000-0001-5514-8887
Andrew WhyteDavenport Laboratories, Department of Chemistry, University of Toronto 80 St. George St. Toronto Ontario M5S 3H6 Canada mark.lautens@utoronto.ca.ORCID https://orcid.org/0000-0001-7261-4309
Mark LautensDavenport Laboratories, Department of Chemistry, University of Toronto 80 St. George St. Toronto Ontario M5S 3H6 Canada mark.lautens@utoronto.ca.ORCID https://orcid.org/0000-0002-0179-2914

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Strategies to capitalize on enolate intermediates generated from stereoselective conjugate borylation to α,β-unsaturated carbonyl systems are surprisingly rare despite the ubiquity of Michael acceptors, and the potential to generate valuable scaffolds bearing multiple stereocenters. Herein, we report a mild and stereoselective copper-catalyzed conjugate borylation/Mannich cyclization reaction. This strategy is feasible with a broad range of Michael acceptors, and can be leveraged to generate versatile borylated tetrahydroquinoline scaffolds bearing three contiguous stereocenters. The synthetic potential of these complex heterocycles has been explored through a series of derivatization studies.

Identifiers

PMID34094079
PMCPMC8159378

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.